欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0490/004
药品名称Propofol Fresenius MCT 20 mg/ml Emulsion zur Injektion/Infusion in einer Fertigspritze
活性成分
    • Propofol 20.0 mg/ml
剂型Emulsion for injection or infusion
上市许可持有人Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1 61352 Bad Homburg Germany
参考成员国 - 产品名称Germany (DE)
Propofol 2 %(20 mg/1 ml) MCT Fresenius Emulsion zur Injektionslösung oder Infusion
互认成员国 - 产品名称
    • Denmark (DK)
      Propolipid
    • Belgium (BE)
    • Iceland (IS)
      Propolipid 20 mg/ml Stungulyf/innrennslislyf, fleyti
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Propofol "Fresenius" 2 % mit MCT Emulsion zur Injektion oder Infusion in einer Fertigspritze
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Propolipid
    • Finland (FI)
    • Poland (PL)
      Propofol 2% MCT/LCT Fresenius
    • Latvia (LV)
      Propoven 2% emulsija injekcijām/infūzijām pilnšļircē
    • Lithuania (LT)
      Propoven 2 % injekcinė ar infuzinė emulsija užpildytame švirkšte
    • Estonia (EE)
      PROPOVEN 2%
    • Hungary (HU)
      PROPOFOL MCT FRESENIUS 20 mg/ml emulziós injekció vagy infúzió előretöltött fecskendőben
    • Cyprus (CY)
      PROPOFOL 2% MCT FRESENIUS KABI
    • Czechia (CZ)
      Propofol 2% MCT/LCT Fresenius
    • Slovakia (SK)
      Propofol 2% MCT Fresenius
    • Slovenia (SI)
许可日期2013/03/12
最近更新日期2025/06/13
药物ATC编码
    • N01AX10 propofol
申请类型
  • TypeLevel1：Line Extension
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase